Papers
10
Total Citations
72
H-Index
5
About
Dr. Jun Watanabe is a leading colorectal surgeon whose research focuses on advancing minimally invasive surgical techniques for gastrointestinal cancers, particularly rectal and colon cancer. His major contributions include spearheading landmark multicenter prospective trials that evaluate the safety and efficacy of laparoscopic and robotic-assisted surgeries. The PRODUCT trial (2022, 19 citations) validated laparoscopic surgery for locally advanced rectal cancer using circumferential resection margin (CRM) and total mesorectal excision (TME) quality as key endpoints, while the VITRUVIANO trial (2024, 17 citations) established the feasibility of robotic-assisted surgery in this context. Dr. Watanabe also led the ROBOCOLO trial (2023, 7 citations), demonstrating the safety of robotic surgery for right-sided colon cancer in Japan. His work on risk factors for anastomotic leakage (2025, 10 citations) reflects current clinical practices, and he has explored innovative applications such as Avelumab for plasmacytoid variant bladder cancer (2023, 5 citations). With a growing portfolio of over 70 citations across his most-cited papers, Dr. Watanabe’s research is shaping evidence-based standards for minimally invasive colorectal surgery, improving patient outcomes through rigorous prospective studies.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10